New study moves researchers closer to lung cancer blood test
Early signs of lung cancer could be diagnosed using a simple blood test following a new discovery by scientists at the University of York.
Cancer
Oct 15, 2012 |
5 / 5 (1) |
0
|
3-D model for lung cancer mimics the real thing
(Medical Xpress)—A new technique that allows scientists to grow lung cancer cells in three dimensions could accelerate discoveries for a type of cancer that has benefited little from scientific research ...
Cancer
Oct 11, 2012 |
4 / 5 (1) |
0
Gene variant linked with reduced lung cancer risk
A variant in a gene involved with inflammation and the immune response is linked with a decreased risk of lung cancer. That is the finding of an analysis published early online in Cancer, a peer-reviewed journal of the Am ...
Cancer
Oct 08, 2012 |
not rated yet |
0
New mouse model of debilitating lung disease suggests potential treatment regimen
LAM, short for pulmonary lymphangioleiomyomatosis, affects about 1 in 10,000 women of childbearing age and is characterized by proliferation of smooth muscle-like cells in the lung, destruction of lung tissue, and growth ...
Medical research
Oct 03, 2012 |
not rated yet |
0
|
Chemical engineer studies breast cancer by building bone, brain and lung tissues
Shelly Peyton, a chemical engineer at the University of Massachusetts Amherst, says scientists know that breast cancer will spread to many different types of tissues in the body, and that this migration is the key reason ...
Cancer
Oct 03, 2012 |
not rated yet |
0
Breakthrough in understanding lung cancer vulnerabilities points the way to new targeted therapy
More effective treatments for one of the deadliest forms of cancer are one step closer thanks to groundbreaking research from an international collaborative study.
Cancer
Oct 01, 2012 |
5 / 5 (5) |
0
|
First use in patient of conditionally reprogrammed cells delivers clinical response
Using a newly discovered cell technology, Georgetown University Medical Center researchers were able to identify an effective therapy for a patient with a rare type of lung tumor. The single case study, reported in the September ...
Cancer
Sep 27, 2012 |
5 / 5 (1) |
0
|
Researchers develop blood test that accurately detects early stages of lung, breast cancer in humans
Researchers at Kansas State University have developed a simple blood test that can accurately detect the beginning stages of cancer.
Cancer
Sep 26, 2012 |
5 / 5 (4) |
0
|
Key immune cell may play role in lung cancer susceptibility
(Medical Xpress)—Why do many heavy smokers evade lung cancer while others who have never lit up die of the disease? The question has vexed scientists for decades.
Cancer
Sep 21, 2012 |
not rated yet |
0
|
'Half-match' bone marrow transplants wipe out sickle cell disease in selected patients
In a preliminary clinical trial, investigators at Johns Hopkins have shown that even partially-matched bone marrow transplants can eliminate sickle cell disease in some patients, ridding them of painful and debilitating symptoms, ...
Medical research
Sep 20, 2012 |
not rated yet |
0
|
Definition of lung squamous cell carcinoma genome opens doors to better, more targeted therapies
A new paper published online in Nature holds out hope that people with the second most common type of lung cancer may one day benefit from targeted therapies that have transformed treatments for other lung cancer patients.
Cancer
Sep 09, 2012 |
not rated yet |
0
|
Crizotinib reduces tumor size in patients with ALK positive lung cancer
Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase (ALK) positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and should be the standard ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Adding bavituximab to second-line chemotherapy doubles response rate
Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small cell lung cancer (NS-NSCLC) ...
Cancer
Sep 06, 2012 |
5 / 5 (2) |
0
Stage I NSCLC patients who receive radiation therapy are surviving longer
Stage I, non-small cell lung cancer (NSCLC) patients who received radiation therapy have an increased median survival of 21 months compared to 16 months, and the percentage of patients who receive no treatment declined from ...
Cancer
Sep 06, 2012 |
not rated yet |
0
New target found for cancers resistant to Iressa and Herceptin
A more-sensitive method to analyze protein interactions has uncovered a new way that cancer cells may use the cell-surface molecule HER3 to drive tumor progression following treatment with HER1 and HER2 inhibitors.
Cancer
Sep 04, 2012 |
not rated yet |
0
|
